Consumer Health Info: Addyi Health
Flibanserin (brand name: Addyi) is the first drug approved by the U.S. Food and Drug Administration (FDA) to treat lack of sexual desire (Hypoactive Sexual Desire Disorder) in premenopausal women.
Consumer Health Info: Vyleesi
Bremelanotide (brand name: Vyleesi) is a drug approved by the FDA to treat a lack of sexual desire (hypoactive sexual desire disorder) in premenopausal women.
Top 10 Things to Know About Today’s Sex Drive Drugs
Learn about Addyi (flibanserin) and Vyleesi (bremelanotide), FDA-approved drugs designed to treat hypoactive sexual desire disorder (HSDD) in premenopausal women.
FDA Scientific Workshop – Female Sexual Interest/Arousal Disorder
Food and Drug Administration Scientific Workshop on Female Sexual Interest/Arousal Disorder